Tech Company Financing Transactions
Syllable Funding Round
On 4/25/2022, Syllable raised $40 million in Series C investment from TCV, Oak HC/FT and Section 32.
Transaction Overview
Company Name
Announced On
4/25/2022
Transaction Type
Venture Equity
Amount
$40,000,000
Round
Series C
Investors
Proceeds Purpose
Funding will be used to further develop Syllable's main solution, the Syllable Patient Assistant, which meets patients where they are -- on the phone, web, and via SMS.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
PO Box 6238
San Jose, CA 95150
USA
San Jose, CA 95150
USA
Phone
Undisclosed
Website
Email Address
Overview
Syllable is an AI-powered healthcare services company that transforms the way healthcare systems deliver customer service. Long call hold times, rerouted or dropped calls and dead ends can all contribute to a frustrating patient experience and make it cumbersome to access vital care quickly.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Kobus Jooste
Chief Medical Officer
Adam Silverman
Chief Operating Officer
Gui Bastos
VP - Bus. Development
Thomas McCormick
VP - Customer Service
Matthew Gullicksrud
VP - Engineering
Ian Atkinson
VP - Engineering
Andrew Rogers
VP - Finance
Irene Ma
VP - Marketing
Ritu Tandon
VP - Operations
Thomas Truong
VP - Sales
William Lovelace
VP - Sales
Chris MacMinn
VP - Sales
Douglas Schneider
VP - Sales
Trace Zwahlen
Browse more venture capital transactions:
Prev: 4/25/2022: Arrow by Kard Tech venture capital transaction
Next: 4/25/2022: Epitopea venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC transactions reported here are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs